DrugCite
Search

ZICAM NASAL PRODUCTS

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Zicam Nasal Products Adverse Events Reported to the FDA Over Time

How are Zicam Nasal Products adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zicam Nasal Products, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zicam Nasal Products is flagged as the suspect drug causing the adverse event.

Most Common Zicam Nasal Products Adverse Events Reported to the FDA

What are the most common Zicam Nasal Products adverse events reported to the FDA?

Anosmia
239 (38.93%)
Multiple Injuries
90 (14.66%)
Dysgeusia
77 (12.54%)
Hyposmia
76 (12.38%)
Hypogeusia
46 (7.49%)
Ageusia
32 (5.21%)
Injury
14 (2.28%)
Product Quality Issue
8 (1.3%)
Nasal Discomfort
7 (1.14%)
Burning Sensation
4 (.65%)
Unevaluable Event
4 (.65%)
Show More Show More
Haemorrhage
3 (.49%)
Scab
3 (.49%)
Rhinorrhoea
2 (.33%)
Decreased Appetite
1 (.16%)
Dyspnoea
1 (.16%)
Eye Irritation
1 (.16%)
Nasal Congestion
1 (.16%)
Parosmia
1 (.16%)
Rhinalgia
1 (.16%)
Sinus Headache
1 (.16%)
Sneezing
1 (.16%)
Weight Decreased
1 (.16%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Zicam Nasal Products, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zicam Nasal Products is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zicam Nasal Products

What are the most common Zicam Nasal Products adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zicam Nasal Products, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zicam Nasal Products is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zicam Nasal Products According to Those Reporting Adverse Events

Why are people taking Zicam Nasal Products, according to those reporting adverse events to the FDA?

Nasopharyngitis
6
Dyspnoea
1

Zicam Nasal Products Case Reports

What Zicam Nasal Products safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Zicam Nasal Products. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zicam Nasal Products.